首页> 外文期刊>Nutrition Journal >Effect of octanoic acid-rich formula on plasma ghrelin levels in cachectic patients with chronic respiratory disease
【24h】

Effect of octanoic acid-rich formula on plasma ghrelin levels in cachectic patients with chronic respiratory disease

机译:富含辛酸的配​​方对慢性呼吸系统疾病的恶病质患者血浆生长素释放肽水平的影响

获取原文
           

摘要

Background For cachectic patients with chronic respiratory disease (CRD), conventional enteral nutrition formula is an optional treatment to maintain energy balance. The molecular mechanisms by which enteral nutrition formula controls appetite and weight remain unknown. We examined whether enteral nutrition formula rich in octanoic acids would increase plasma levels of ghrelin, an appetite-stimulating hormone produced in the stomach, in cachectic patients with CRD. Methods Plasma ghrelin profiles in cachectic patients with CRD were assessed and compared with those in age- and sex-matched controls. Plasma levels of acyl-ghrelin, an active ghrelin modified by octanoic acids, and desacyl-ghrelin were measured separately. We examined changes in 24-h plasma ghrelin profiles before and after single administration of the formula. We also evaluated the effects of 2-week administration of the formula on plasma ghrelin levels and nutritional status in patients. Results The ratio of acyl-ghrelin to desacyl-ghrelin in plasma was lower in patients than in controls. Single administration of the formula did not change plasma desacyl-ghrelin levels, but induced an increase in acyl-ghrelin levels. Two-week treatment with the formula was effective in increasing weight and acyl-ghrelin, along with improving nutritional status in patients. Conclusion These results show that the formula contributes to increased weight, which may be associated with induction of acyl-ghrelin production in cachectic patients with CRD.
机译:背景技术对于患有慢性呼吸道疾病(CRD)的恶病质患者,常规肠内营养配方食品是维持能量平衡的一种可选治疗方法。肠内营养配方控制食欲和体重的分子机制仍然未知。我们检查了富含辛酸的肠内营养配方食品是否会增加恶病质CRD患者的血浆ghrelin的水平,ghrelin是胃中产生的食欲刺激激素。方法评估恶病质CRD患者的血浆生长素释放肽谱,并将其与年龄和性别相匹配的对照组进行比较。分别测量血浆中的ghrelin,被辛酸修饰的活性ghrelin和desacyl-ghrelin的血浆水平。我们检查了单次服用该制剂前后24小时血浆生长素释放肽的变化。我们还评估了2周服用该配方对血浆生长素释放肽水平和患者营养状况的影响。结果患者血浆中的血浆Ghrelin与Desacyl Ghrelin的比例低于对照组。该配方的单次给药并没有改变血浆脱酰基-生长素释放肽的水平,但是诱导了酰基-生长素释放肽水平的增加。用该配方进行两周的治疗可有效增加体重和酰基ghrelin,并改善患者的营养状况。结论这些结果表明该配方有助于体重增加,这可能与诱导恶病质CRD患者的酰基-ghrelin产生有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号